The comparative genomics and phylogenomics of Leishmania amazonensis parasite

Evolutionary Bioinformatics

Volumn 10, Issue , 2014, Pages 131-153

  Tschoeke, Diogo A ^a   Nunes, Gisele L ^a   Jardim, Rodrigo ^a   Lima, Joana ^a   Dumaresq, Aline S R ^a   Gomes, Monete R ^a   Pereira, Leandro de Mattos ^a   Loureiro, Daniel R ^a   Stoco, Patricia H ^b   de Matos Guedes, Herbert Leonel ^c,d   de Miranda, Antonio Basilio ^a   Ruiz, Jeronimo ^a   Pitaluga, André ^a   Silva, Floriano P ^a   Probst, Christian M ^a,e   Dickens, Nicholas J ^d   Mottram, Jeremy C ^d   Grisard, Edmundo C ^b   Dávila, Alberto M R ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e INSTITUTO CARLOS CHAGAS   (Brazil)

Author keywords

Comparative genomics; Leishmania amazonensis; Phylogenomics

Indexed keywords

PROTOZOAL PROTEIN;

ARTICLE; COMPARATIVE GENOMICS; GENOME; GENOME ANALYSIS; GENOMICS; LEISHMANIA; LEISHMANIA BRAZILIENSIS; LEISHMANIA DONOVANI; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; LEISHMANIA MEXICANA; NONHUMAN; NUCLEOTIDE SEQUENCE; ORTHOLOGY; PHYLOGENOMICS; PROTEIN ANALYSIS; RNA INTERFERENCE; SEQUENCE ANALYSIS; SYNTENY;

LEISHMANIA AMAZONENSIS;

EID: 84907813667     PISSN: None     EISSN: 11769343     Source Type: Journal    
DOI: 10.4137/EBO.S13759     Document Type: Article

References (108)

1. Choi J, El-Sayed NM. Functional genomics of trypanosomatids. Parasite Immunol. 2012;34(2-3):72-9.
2. Desjeux P. Leishmaniasis. Public health aspects and control. Clin Dermatol. 1996;14(5):417-23.
3. WHO. World Health Statistics; 2010. Available at http://www.who.int/whosis/whostat/2010/en/. Accessed April 8, 2013.
4. Passos VM, Fernandes O, Lacerda PA, et al. Leishmania (Viannia) braziliensis is the predominant species infecting patients with American cutaneous leishmaniasis in the State of Minas Gerais, Southeast Brazil. Acta Trop. 1999;72(3):251-8.
5. TDR. Leishmaniasis; 2013. Available at http://www.who.int/tdr/diseases-topics/Leishmaniasis/en/index.html. Accessed April 11, 2013.
6. Barral A, Pedral-Sampaio D, Grimaldi JúniorG, et al. Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am J Trop Med Hyg. 1991;44(5):536-46.
7. Grimaldi G, McMahan-Pratt D. Leishmaniasis and its etiologic agents in the New World: an overview. Prog Clin Parasitol. 1991;2:73-118.
8. Weigle K, Saravia NG. Natural history, clinical evolution, and the host-parasite interaction in New World cutaneous Leishmaniasis. Clin Dermatol. 1996;14(5):433-50.
9. Chappuis F, Sundar S, Hailu A, et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol. 2007;5(11):873-82.
10. Akilov OE, Khachemoune A, Hasan T. Clinical manifestations and classification of Old World cutaneous leishmaniasis. Int J Dermatol. 2007;46(2):132-42.
11. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004;27(5):305-18.
12. Marsden PD. Mucosal leishmaniasis ("espundia" Escomel, 1911). Trans R Soc Trop Med Hyg. 1986;80(6):859-76.
13. Cupolilo SMN, Souza CSF, Abreu-Silva AL, Calabrese KS. Goncalves da Costa SC. Biological behavior of Leishmania (L.) amazonensis isolated from a human diffuse cutaneous leishmaniasis in inbred strains of mice. Histol Histopathol. 2003;18(4):1059-65.
14. Mayrink W, Mendonça-Mendes A, de Paula JC, et al. Cluster randomised trial to evaluate the effectiveness of a vaccine against cutaneous leishmaniasis in the Caratinga microregion, south-east Brazil. Trans R Soc Trop Med Hyg. 2013;107(4):212-9.
15. Ivens AC, Peacock CS, Worthey EA, et al. The genome of the kinetoplastid parasite, Leishmania major. Science. 2005;309(5733):436-42.
16. Berriman M, Ghedin E, Hertz-Fowler C, et al. The genome of the African trypanosome Trypanosoma brucei. Science. 2005;309(5733):416-22.
17. El-Sayed NM, Myler PJ, Bartholomeu DC, et al. The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science. 2005;309(5733):409-15.
18. Peacock CS, Seeger K, Harris D, et al. Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat Genet. 2007;39(7):839-47.
19. Laurentino EC, Ruiz JC, Fazelinia G, et al. A survey of Leishmania braziliensis genome by shotgun sequencing. Mol Biochem Parasitol. 2004;137(1):81-6.
20. Denise H, Poot J, Jiménez M, et al. Studies on the CPA cysteine peptidase in the Leishmania infantum genome strain JPCM5. BMC Mol Biol. 2006;7:42.
21. Rogers MB, Hilley JD, Dickens NJ, et al. Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania. Genome Res. 2011;21(12):2129-42.
22. Real F, Vidal RO, Carazzolle MF, et al. The genome sequence of Leishmania (Leishmania) amazonensis: functional annotation and extended analysis of gene models. DNA Res. 2013.
23. El-Sayed NM, Myler PJ, Blandin G, et al. Comparative genomics of trypanosomatid parasitic protozoa. Science. 2005;309(5733):404-9.
24. Teixeira SM, de Paiva RMC, Kangussu-Marcolino MM, Darocha WD. Trypanosomatid comparative genomics: contributions to the study of parasite biology and different parasitic diseases. Genet Mol Biol. 2012;35(1):1-17.
25. Ewing B, Green P. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res. 1998;8(3):186-94.
26. Ewing B, Hillier L, Wendl MC, Green P. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res. 1998;8(3):175-85.
27. Zerbino DR, Birney E. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res. 2008;18(5):821-9.
28. Glauber Wagner, Rodrigo Jardim, Diogo A Tschoeke, et al. STINGRAY: system for integrated genomic resources and analysis. BMC Research Notes. 2014;7:132.
29. Dávila AM, Lorenzini DM, Mendes PN, et al. GARSA: genomic analysis resources for sequence annotation. Bioinformatics. 2005;21(23):4302-3.
30. Altschul SF, Madden TL, Schäffer AA, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997;25(17):3389-402.
31. Bateman A, Birney E, Cerruti L, et al. The Pfam protein families database. Nucleic Acids Res. 2002;30(1):276-80.
32. Punta M, Coggill PC, Eberhardt RY, et al. The Pfam protein families database. Nucleic Acids Res. 2012;40(Database issue):D290-301.
33. Mistry J, Finn RD, Eddy SR, Bateman A, Punta M. Challenges in homology search: HMMER3 and convergent evolution of coiled-coil regions. Nucleic Acids Res. 2013;41(12):e121.
34. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25(1):25-9.
35. Li L, Stoeckert CJ, Roos DS. OrthoMCL: identification of ortholog groups for eukaryotic genomes. Genome Res. 2003;13(9):2178-89.
36. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2013 Isbn3-900051-07-0.
37. Ocaña KACS, Dávila AMR. Phylogenomics-based reconstruction of protozoan species tree. Evol Bioinform Online. 2011;7:107-21.
38. Ciccarelli FD, Doerks T, von Mering C, Creevey CJ, Snel B, Bork P. Toward automatic reconstruction of a highly resolved tree of life. Science. 2006;311(5765):1283-7.
39. Dávila AM, Mendes PN, Wagner G, et al. ProtozoaDB: dynamic visualization and exploration of protozoan genomes. Nucleic Acids Res. 2008;36(Database issue):D547-52.
40. Katoh K, Kuma K, Toh H, Miyata T. MAFFT version 5: improvement in accuracy of multiple sequence alignment. Nucleic Acids Res. 2005;33(2):511-8.
41. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28(10):2731-9.
42. Jones DT, Taylor WR, Thornton JM. The rapid generation of mutation data matrices from protein sequences. Comput Appl Biosci. 1992;8(3):275-82.
43. Otto TD, Guimarães ACR, Degrave WM, de Miranda AB. AnEnPi: identification and annotation of analogous enzymes. BMC Bioinformatics. 2008;9:544.
44. Alves-Ferreira M, Guimarães ACR, Capriles PV, Dardenne LE, Degrave WM. A new approach for potential drug target discovery through in silico metabolic pathway analysis using Trypanosoma cruzi genome information. Mem Inst Oswaldo Cruz. 2009;104(8):1100-10.
45. Gomes MR, Guimarães ACR, de Miranda AB. Specific and nonhomologous isofunctional enzymes of the genetic information processing pathways as potential therapeutical targets for tritryps. Enzyme Res. 2011;2011:543912.
46. Barrett AJ. Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (NC-IUBMB). Enzyme Nomenclature. Recommendations 1992. Supplement 4: corrections and additions (1997). Eur J Biochem. 1997;250(1):1-6.
47. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 2012;40(Database issue):D109-14.
48. Capriles PVSZ, Guimarães ACR, Otto TD, Miranda AB, Dardenne LE, Degrave WM. Structural modelling and comparative analysis of homologous, analogous and specific proteins from Trypanosoma cruzi versus Homo sapiens: putative drug targets for Chagas' disease treatment. BMC Genomics. 2010;11:610.
49. Andreeva A, Howorth D, Chandonia JM, et al. Data growth and its impact on the SCOP database: new developments. Nucleic Acids Res. 2008;36(Database issue):D419-25.
50. Wilson D, Pethica R, Zhou Y, et al. SUPERFAMILY - sophisticated comparative genomics, data mining, visualization and phylogeny. Nucleic Acids Res. 2009;37(Database issue):D380-6.
51. Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol. 1993;234(3):779-815.
52. Rice P, Longden I, Bleasby A. EMBOSS: the European molecular biology open software suite. Trends Genet. 2000;16(6):276-7.
53. Tatusov RL, Koonin EV, Lipman DJ. A genomic perspective on protein families. Science. 1997;278(5338):631-7.
54. Tatusov RL, Fedorova ND, Jackson JD, et al. The COG database: an updated version includes eukaryotes. BMC Bioinformatics. 2003;4:41.
55. Logan-Klumpler FJ, De SilvaN, Boehme U, et al. GeneDB - an annotation database for pathogens. Nucleic Acids Res. 2012;40(Database issue):D98-108.
56. Assefa S, Keane TM, Otto TD, Newbold C, Berriman M. ABACAS: algorithm-based automatic contiguation of assembled sequences. Bioinformatics. 2009;25(15):1968-9.
57. Carver TJ, Rutherford KM, Berriman M, Rajandream M-A, Barrell BG, Parkhill J. ACT: the artemis comparison tool. Bioinformatics. 2005;21(16):3422-3.
58. Saurin W, Hofnung M, Dassa E. Getting in or out: early segregation between importers and exporters in the evolution of ATP-binding cassette (ABC) transporters. J Mol Evol. 1999;48(1):22-41.
59. Sauvage V, Aubert D, Escotte-Binet S, Villena I. The role of ATP-binding cassette (ABC) proteins in protozoan parasites. Mol Biochem Parasitol. 2009;167(2):81-94.
60. Leprohon P, Légaré D, Girard I, Papadopoulou B, Ouellette M. Modulation of Leishmania ABC protein gene expression through life stages and among drug-resistant parasites. Eukaryot Cell. 2006;5(10):1713-25.
61. Torres DC, Adaui V, Ribeiro-Alves M, et al. Targeted gene expression profiling in Leishmania braziliensis and Leishmania guyanensis parasites isolated from Brazilian patients with different antimonial treatment outcomes. Infect Genet Evol. 2010;10(6):727-33.
62. Mottram JC, Coombs GH, Alexander J. Cysteine peptidases as virulence factors of Leishmania. Curr Opin Microbiol. 2004;7(4):375-81.
63. Ersfeld K, Barraclough H, Gull K. Evolutionary relationships and protein domain architecture in an expanded calpain superfamily in kinetoplastid parasites. J Mol Evol. 2005;61(6):742-57.
64. d'Avila-Levy CM, Marinho FA, Santos LO, Martins JL, Santos ALS, Branquinha MH. Antileishmanial activity of MDL 28170, a potent calpain inhibitor. Int J Antimicrob Agents. 2006;28(2):138-42.
65. Raymond F, Boisvert S, Roy G, et al. Genome sequencing of the lizard parasite Leishmania tarentolae reveals loss of genes associated to the intracellular stage of human pathogenic species. Nucleic Acids Res. 2012;40(3):1131-47.
66. Stiles JK, Hicock PI, Shah PH, Meade JC. Genomic organization, transcription, splicing and gene regulation in Leishmania. Ann Trop Med Parasitol. 1999;93(8):781-807.
67. Eresh S, McCallum SM, Barker DC. Identification and diagnosis of Leishmania mexicana complex isolates by polymerase chain reaction. Parasitology. 1994;109(pt 4):423-33.
68. Rochette A, McNicoll F, Girard J, et al. Characterization and developmental gene regulation of a large gene family encoding amastin surface proteins in Leishmania spp. Mol Biochem Parasitol. 2005;140(2):205-20.
69. Jackson AP. The evolution of amastin surface glycoproteins in trypanosomatid parasites. Mol Biol Evol. 2010;27(1):33-45.
70. Grover A, Kumar Shakyawar S, Saudagar P, Kumar Dubey V, Sundar D. Epitopic analysis of potential vaccine candidate in Leishmania infantum for development of human vaccine. Lett Drug Des Discov. 2012;9(7):698-705.
71. Rafati S, Hassani N, Taslimi Y, Movassagh H, Rochette A, Papadopoulou B. Amastin peptide-binding antibodies as biomarkers of active human visceral leishmaniasis. Clin Vaccine Immunol. 2006;13(10):1104-10.
72. Aleixo JA, Nascimento ET, Monteiro GR, et al. Atypical American visceral leishmaniasis caused by disseminated Leishmania amazonensis infection presenting with hepatitis and adenopathy. Trans R Soc Trop Med Hyg. 2006;100(1):79-82.
73. Mestra L, Lopez L, Robledo SM, Muskus CE, Nicholls RS, Vélez ID. Transfusion-transmitted visceral leishmaniasis caused by Leishmania (Leishmania) mexicana in an immunocompromised patient: a case report. Transfusion. 2011;51(9):1919-23.
74. Yao C, Donelson JE, Wilson ME. The major surface protease (MSP or GP63) of Leishmania sp. Biosynthesis, regulation of expression, and function. Mol Biochem Parasitol. 2003;132(1):1-16.
75. Mauricio IL, Gaunt MW, Stothard JR, Miles MA. Glycoprotein 63 (gp63) genes show gene conversion and reveal the evolution of Old World Leishmania. Int J Parasitol. 2007;37(5):565-76.
76. Ma L, Chen K, Meng Q, et al. An evolutionary analysis of trypanosomatid GP63 proteases. Parasitol Res. 2011;109(4):1075-84.
77. Downing T, Imamura H, Decuypere S, et al. Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance. Genome Res. 2011;21(12):2143-56.
78. Sharma U, Singh S. Insect vectors of Leishmania: distribution, physiology and their control. J Vector Borne Dis. 2008;45(4):255-72.
79. Croan DG, Morrison DA, Ellis JT. Evolution of the genus Leishmania revealed by comparison of DNA and RNA polymerase gene sequences. Mol Biochem Parasitol. 1997;89(2):149-59.
80. Mauricio IL, Howard MK, Stothard JR, Miles MA. Genomic diversity in the Leishmania donovani complex. Parasitology. 1999;119(pt 3):237-46.
81. Simpson AGB, Gill EE, Callahan HA, Litaker RW, Roger AJ. Early evolution within kinetoplastids (euglenozoa), and the late emergence of trypanosomatids. Protist. 2004;155(4):407-22.
82. Cunningham ML, Fairlamb AH. Trypanothione reductase from Leishmania donovani. Purification, characterisation and inhibition by trivalent antimonials. Eur J Biochem. 1995;230(2):460-8.
83. Widmer G, Comeau AM, Furlong DB, Wirth DF, Patterson JL. Characterization of a RNA virus from the parasite Leishmania. Proc Natl Acad Sci U S A. 1989;86(15):5979-82.
84. Lukes J, Mauricio IL, Schönian G, et al. Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy. Proc Natl Acad Sci U S A. 2007;104(22):9375-80.
85. Fraga J, Montalvo AM, Van der Auwera G, Maes I, Dujardin J-C, Requena JM. Evolution and species discrimination according to the Leishmania heat-shock protein 20 gene. Infect Genet Evol. 2013;18:229-37.
86. Ilari A, Baiocco P, Messori L, et al. A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition. Amino Acids. 2012;42(2-3):803-11.
87. Lindahl T, Demple B, Robins P. Suicide inactivation of the E. coli O6-methylguanine-DNA methyltransferase. EMBO J. 1982;1(11):1359-63.
88. Sultana R, McNeill DR, Abbotts R, et al. Synthetic lethal targeting of DNA double-strand break repair deficient cells by human apurinic/apyrimidinic endonuclease inhibitors. Int J Cancer. 2012;131(10):2433-44.
89. Doun SS, Burgner JW, Briggs SD, Rodwell VW. Enterococcus faecalis phosphomevalonate kinase. Protein Sci. 2005;14(5):1134-9.
90. Wiesner J, Jomaa H. Isoprenoid biosynthesis of the apicoplast as drug target. Curr Drug Targets. 2007;8(1):3-13.
91. Yin L, Mano J, Wang S, Tsuji W, Tanaka K. The involvement of lipid peroxide-derived aldehydes in aluminum toxicity of tobacco roots. Plant Physiol. 2010;152(3):1406-17.
92. Mano J, Belles-Boix E, Babiychuk E, et al. Protection against photooxidative injury of tobacco leaves by 2-alkenal reductase. Detoxication of lipid peroxide-derived reactive carbonyls. Plant Physiol. 2005;139(4):1773-83.
93. Krungkrai SR, Krungkrai J. Malaria parasite carbonic anhydrase: inhibition of aromatic/heterocyclic sulfonamides and its therapeutic potential. Asian Pac J Trop Biomed. 2011;1(3):233-42.
94. Reungprapavut S, Krungkrai SR, Krungkrai J. Plasmodium falciparum carbonic anhydrase is a possible target for malaria chemotherapy. J Enzyme Inhib Med Chem. 2004;19(3):249-56.
95. Vidal AE, Harkiolaki M, Gallego C, et al. Crystal structure and DNA repair activities of the AP endonuclease from Leishmania major. J Mol Biol. 2007;373(4):827-38.
96. Nowicki MW, Kuaprasert B, McNae IW, et al. Crystal structures of Leishmania mexicana phosphoglycerate mutase suggest a one-metal mechanism and a new enzyme subclass. J Mol Biol. 2009;394(3):535-43.
97. Ngô H, Tschudi C, Gull K, Ullu E. Double-stranded RNA induces mRNA degradation in Trypanosoma brucei. Proc Natl Acad Sci U S A. 1998;95(25):14687-92.
98. Robinson KA, Beverley SM. Improvements in transfection efficiency and tests of RNA interference (RNAi) approaches in the protozoan parasite Leishmania. Mol Biochem Parasitol. 2003;128(2):217-28.
99. Lye LF, Owens K, Shi H, et al. Retention and loss of RNA interference pathways in trypanosomatid protozoans. PLoS Pathog. 2010;6(10):e1001161.
100. Cerutti H, Casas-Mollano JA. On the origin and functions of RNA-mediated silencing: from protists to man. Curr Genet. 2006;50(2):81-99.
101. Shi H, Tschudi C, Ullu E. An unusual Dicer-like1 protein fuels the RNA interference pathway in Trypanosoma brucei. RNA. 2006;12(12):2063-72.
102. Pavelec DM, Lachowiec J, Duchaine TF, Smith HE, Kennedy S. Requirement for the ERI/DICER complex in endogenous RNA interference and sperm development in Caenorhabditis elegans. Genetics. 2009;183(4):1283-95.
103. Durand-Dubief M, Bastin P. TbAGO1, an argonaute protein required for RNA interference, is involved in mitosis and chromosome segregation in Trypanosoma brucei. BMC Biol. 2003;1:2.
104. Gabel HW, Ruvkun G. The exonuclease ERI-1 has a conserved dual role in 5.8S rRNA processing and RNAi. Nat Struct Mol Biol. 2008;15(5):531-3.
105. Hutvagner G, Simard MJ. Argonaute proteins: key players in RNA silencing. Nat Rev Mol Cell Biol. 2008;9(1):22-32.
106. Padmanabhan PK, Dumas C, Samant M, Rochette A, Simard MJ, Papadopoulou B. Novel features of a PIWI-like protein homolog in the parasitic protozoan Leishmania. PLoS One. 2012;7(12):e52612.
107. Bates PA. Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies. Int J Parasitol. 2007;37(10):1097-106.
108. Bañuls A-L, Hide M, Prugnolle F. Leishmania and the leishmaniases: a parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans. Adv Parasitol. 2007;64:1-109.